Keith Houlihan, president and chief executive officer of Sanomedics International, has announced the launch of Sanomedics Development Corporation. The new corporation will be led by Abhishek Shrivastava, chief
The FDA has approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by
Catalent has reported the successful completion of the first FDA general cGMP audit and pre-approval inspection of its Buenos Aires, Argentina pharmaceutical softgel facility, with no reported observations
Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed. SRL will distribute miRview mets,
Czech Republic-based contract manufacturing organisation, Medis International has completed construction of its new 2,700sqm pharma packaging plant in Bolatice, reported in-Pharma Technologist. Reportedly, the company officials said that
Forest Laboratories and Glenmark Pharmaceuticals, a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a phase IIb dose range-finding study of oglemilast in
Sasol has announced the initiation of consultations with various stakeholders ahead of a possible closure of Sasol Nitro’s phosphoric acid operations in Phalaborwa. The plant, which manufactures phosphoric
Roche has announced that a phase III study of Avastin (bevacizumab), in combination with a range of chemotherapies, met its primary endpoint. The study met the objective of
Xceleron has signed a second Master Service Agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Xceleron will provide analytical support to GSK and its affiliated research
Amcor has offered to acquire parts of Alcan Packaging for $2.02b from Rio Tinto. The Alcan Packaging businesses which Amcor has agreed to acquire include, Alcan Packaging Global
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.